Invesco Asia Trust — Opportunities emerging in Asian equities

Invesco Asia Trust (LSE: IAT)

Last close As at 22/11/2024

GBP3.40

−2.00 (−0.58%)

Market capitalisation

GBP221m

More on this equity

Research: Investment Companies

Invesco Asia Trust — Opportunities emerging in Asian equities

Invesco Asia Trust (IAT) aims to deliver significant capital gains to shareholders over a three- to five-year horizon, primarily through investing in Asian equities, following a disciplined, bottom-up process. It has a solid long-term track record of NAV total return outperformance against its benchmark and has delivered annualised returns of 13% pa over the past 10 years. Although the primary objective is capital gains, since 2001 IAT has also consistently maintained or grown dividends, which increased 28% in FY18. The MSCI Asia ex-Japan index has corrected nearly 20% from its January 2018 peak and the manager believes many interesting investment ideas are emerging.

Analyst avatar placeholder

Written by

Investment Companies

Invesco Asia Trust

Opportunities emerging in Asian equities

Investment trusts

18 September 2018

Price

271.0p

Market cap

£192.2m

AUM

£219.2m

NAV*

306.4p

Discount to NAV

11.6%

NAV**

310.8p

Discount to NAV

12.8%

*Excluding income. **Including income. As at 14 September 2018.

Yield

2.0%

Ordinary shares in issue

70.9m

Code

IAT

Primary exchange

LSE

AIC sector

Asia Pacific ex-Japan

Benchmark

MSCI AC Asia ex-Japan

Share price/discount performance

Three-year performance vs index

52-week high/low

310.5p

268.0p

347.8p

304.9p

**Including income.

Gearing

Gross*

0.0%

Net cash*

3.8%

*As at 31 July 2018.

Analysts

Helena Coles

+44 (0)20 3077 5700

Mel Jenner

+44 (0)20 3077 5720

Invesco Asia Trust is a research client of Edison Investment Research Limited

Invesco Asia Trust (IAT) aims to deliver significant capital gains to shareholders over a three- to five-year horizon, primarily through investing in Asian equities, following a disciplined, bottom-up process. It has a solid long-term track record of NAV total return outperformance against its benchmark and has delivered annualised returns of 13% pa over the past 10 years. Although the primary objective is capital gains, since 2001 IAT has also consistently maintained or grown dividends, which increased 28% in FY18. The MSCI Asia ex-Japan index has corrected nearly 20% from its January 2018 peak and the manager believes many interesting investment ideas are emerging.

12 months ending

Share price
(%)

NAV
(%)

Benchmark*
(%)

MSCI World
(%)

FTSE All-Share
(%)

31/08/14

23.5

23.6

13.0

13.4

10.3

31/08/15

(9.2)

(10.4)

(12.7)

4.1

(2.3)

31/08/16

39.3

39.3

33.0

26.0

11.7

31/08/17

26.9

28.0

27.2

18.8

14.3

31/08/18

(1.1)

0.8

2.2

12.7

4.7

Source: Thomson Datastream. Note: All % on a total return basis in GBP. *Benchmark is MSCI AC Asia Pacific ex-Japan until 30 April 2015 and MSCI AC Asia ex-Japan thereafter.

Investment strategy: Valuation discipline

IAT follows a bottom-up investment process to identify well-managed companies with strong business franchises and robust balance sheets. Valuation is of particular importance and the manager looks for stocks that are intrinsically undervalued on a long-term view. Stock selection leads portfolio construction and IAT’s holdings of 50-70 investments represent the manager’s highest conviction ideas. The rigorous approach, which involves around 700 company visits pa, is supported by a team of six experienced Asian equities specialists.

Market outlook: Asia trading at discount to global

MSCI Asia ex-Japan index peaked in late January 2018, following a strong two-year rally fuelled by easy monetary conditions, including unprecedentedly low interest rates and synchronous global growth. The outlook is now more challenging as interest rates are rising, and monetary conditions are less accommodative. Asian equity markets have responded with a near 20% correction from the peak, although global equities have continued to appreciate. Meanwhile, 2017 earnings in the region have been stronger than expected, bringing valuations close to historic averages, but at a significant discount to global equities.

Valuation: 11.6% discount to ex-income NAV

IAT currently trades on a 11.6% discount to ex-income NAV, which is slightly deeper than the three-year average of 10.4%. The board is committed to managing the discount and views a level below 10.0% to be desirable, in normal market conditions. Dividends have grown, or been maintained, consistently over the long term and the FY18 dividend increased 27.9% to 5.5p per share, representing a yield of 2.0%, which is above the peer group average.

Exhibit 1: Trust at a glance

Investment objective and fund background

Recent developments

IAT’s objective is to provide long-term capital growth by investing in a diversified portfolio of Asian companies. On 1 May 2015 the trust adopted a new benchmark, MSCI AC Asia ex-Japan, in place of the former benchmark, MSCI AC Asia Pacific ex-Japan. While the new benchmark excludes Australasia, the trust may still invest in these markets.

31 July 2018 AGM: Carol Ferguson retired as chairman and was replaced by Neil Rogan.

28 June 2018: Annual report for 12 months ending 30 April 2018. NAV TR +14.5% versus benchmark TR +16.8%. Share price TR +13.0%.

14 December 2017: Interim report for six months ending 31 October 2017. NAV TR +14.8% versus benchmark TR +15.5%. Share price TR +13.4%.

11 August 2017: 12.5m shares repurchased for cancellation in tender offer at a 312.9p per share.

10 August 2017: Neil Rogan appointed as a non-executive director.

Forthcoming

Capital structure

Fund details

AGM

August 2019

Ongoing charges

0.98% (July 2018)

Group

Invesco Asset Management Ltd

Interim results

December 2018

Net cash

3.8%

Manager

Ian Hargreaves

Year end

30 April

Annual mgmt fee

0.75%

Address

125 London Wall
London EC2Y 5AS

Dividend paid

August

Performance fee

None

Launch date

July 1995

Trust life

Indefinite

Phone

+44 (0)20 3753 1000

Continuation vote

Three-yearly, next in 2019

Loan facilities

£20m multi-currency

Website

www.invescoperpetual.co.uk

Dividend policy and history (financial years)

Share buyback policy and history (financial years)

Dividends are paid annually in August. Income is a by-product of stock selection and there is no yield target.

Renewed annually, the trust has authority to purchase up to 14.99% and allot up to 5% of issued share capital.

Shareholder base (as at 3 September 2018)

Portfolio exposure by sector (as at 31 July 2018, ex-cash)

Top 10 holdings (as at 31 July 2018)

Portfolio weight %

Company

Country

Sector

31 July 2018

31 July 2017*

Samsung Electronics

South Korea

Technology hardware & equipment

5.6

8.1

AIA

Hong Kong

Insurance

4.3

3.5

HDFC Bank

India

Banks

4.0

3.7

TSMC

Taiwan

Semiconductors & semiconductor equipment

3.9

3.5

Baidu (ADR)

China

Software & services

3.5

4.2

Tencent

Hong Kong

Software & services

3.2

N/A

JD.com (ADR)

China

Retailing

3.1

N/A

CNOOC

China

Oil & gas

3.0

N/A

Infosys (ADR)

India

Software & services

2.8

N/A

Hyundai Motor (preference shares)

South Korea

Automobiles

2.7

3.3

Top 10

36.1

38.5

Source: Invesco Asia Trust, Edison Investment Research, Bloomberg, Morningstar. Note: *N/A where not in end-July 2017 top 10.

Market outlook: Less benign environment

The MSCI Asia ex-Japan index performed strongly between early 2016 and 2018, fuelled by synchronous global growth, exceptionally accommodative monetary conditions and positive earnings momentum. Many of these factors are now less benign as interest rates are rising, while global leading economic indicators have started to roll over (although they remain strong in the US, underpinned by the impact of recent tax reforms). Equity markets globally are also more volatile than before, as indicated by the sharp increase in the VIX since late January 2018, signalling investors have become more sensitive to risk. As shown in Exhibit 2 (LHS), the MSCI Asia ex-Japan has correctly sharply by around 18% since late-January, while the MSCI World Index (led by US equities) has continued to reach new highs. Coupled with stronger than expected earnings growth of around 23% for 2017, Asia’s valuations have moderated, and are trading close to their 10-year averages, while the discount to global equities has widened meaningfully.

Exhibit 2: Market performance and valuation

Performance of indices (last five years, all in £)

DS Asia ex-Japan vs DS World valuation comparison

Source: Thomson Datastream, Edison Investment Research. Note: Valuation data as at 7 September 2018.

Fund profile: Bottom-up, valuation focused

IAT was launched in 1995 and aims to provide long-term capital growth through investing in a diversified portfolio of Asian and Australasian companies across the whole market cap spectrum. The trust has been benchmarked against the MSCI AC Asia ex-Japan index since 1 May 2015 (previously the MSCI Asia Pacific ex-Japan index) to better reflect its habitual low exposure to Australasia. Fund manager Ian Hargreaves and a team of six Asian equities specialists follow a bottom-up approach to select fundamentally attractive, intrinsically undervalued stocks with a three- to five-year investment horizon. The portfolio typically consists of 50-70 high conviction names. Gearing of up to 25% of the portfolio is permitted; however, in practice, it is used conservatively.

The fund manager: Ian Hargreaves

The manager’s view: Correction brings opportunities

Hargreaves believes Asian equity valuations already reflect a more challenging outlook compared to the benign conditions of the past few years. Early in 2018 he identified a number of headwinds which have become apparent, including a shift to tighter monetary conditions globally, slowing credit growth in China as it sought to mitigate risk in the shadow banking sector, and a peaking in global leading indicators feeding through to moderating export growth from above-trend levels. In his view, a market correction has brought Asian valuations to levels where historically, attractive long-term gains have been made.

The manager also believes Asian economies and corporates, as a whole, are in relatively good shape, sharing few of the fragilities of the emerging markets asset class. However, Hargreaves thinks investors often fail to make this distinction and Asian equities can suffer unjustifiably during indiscriminate ‘risk-off’ market sell-offs. Most Asian countries have strengthened their balance of payment and current account positions over the past five years (which are vastly improved compared to the previous cycle peak in 2009). Meanwhile, corporates have been cautious and capital expenditure has been weak. This has helped to reduce the acute excess capacity problems across many industries over the past years (especially in China), which have hindered profitability. Many companies have much improved free cash flow and carry high levels of cash on their balance sheets, which the manager believes offers some downside protection, as well as prospects for growth in dividends. In this environment, Hargreaves is finding interesting investment opportunities.

Asset allocation

Investment process: Looking for intrinsic undervaluation

The investment process is active and fundamental in its approach to identify companies with attractive market positions, robust financials, strong managements and that trade below their long-term intrinsic values. A team of six Asian equities specialists travel regularly to the region and conduct around 700 company visits pa, with candidate companies subject to rigorous analysis. Valuation is paramount to the investment process and a shortlist of potential investments is ranked by their potential return over a three-year horizon. This bottom-up process is the key driver of portfolio construction, but it is also influenced by the team’s top-down macroeconomic analysis, which helps guide country and sector weights. Risks are managed through ensuring a diversified portfolio of 50-70 stocks across countries and sectors and in-depth knowledge of portfolio companies, involving ongoing monitoring and dialogues with managements. The team and the portfolio are also subject to regular ‘CIO challenges’, facilitated by the Invesco Perpetual Investment Oversight team, which provides constructive scrutiny over the decisions taken within the portfolio, including assumptions, performance review and attributions, and the conviction level of stock decisions.

Current portfolio positioning

IAT is well diversified across 11 countries and sectors and there has been relatively modest activity since our report in March 2018. The portfolio remains overweight India and South Korea. India is at an early stage of a recovery cycle, particularly for banks, where the manager also sees positive structural trends as government measures to address impaired loans are starting to bear fruit. The private sector banks should be the main beneficiaries of these policies and are well-placed to take market share from banks in the state sector, which still commands a 70% industry share, but are under-capitalised and poorly managed. The manager has been adding to Indian financials, and portfolio holdings in this sector include ICICI Bank and companies within the HDFC Group, which Hargreaves believes have potential for high-teens, multi-year growth. South Korea has many cash-rich companies, and traditionally, dividend payout ratios have been low, while deployment of excess capital has often disappointed the international investment community. These factors partly explain the market’s low multiples relative to the region. Hargreaves believes this trend is changing, led by the South Korea’s largest company, Samsung Electronics, which has committed to allocate a minimum of 50% of free cash flow to be returned to shareholders. Other companies are moving in this direction, encouraged by a government focused on improving corporate governance and generating better returns for the National Pension Service. The manager believes there is scope for the South Korean equity market to re-rate over time.

Exhibit 3: Portfolio geographic exposure vs benchmark (% unless stated)

Portfolio end-July 2018

Portfolio end-July 2017

Change (pp)

Benchmark weight

Active weight vs index (pp)

Trust weight/ index weight (x)

Hong Kong and China

42.2

39.8

2.5

47.1

(4.9)

0.9

South Korea

18.2

22.0

(3.8)

16.2

2.0

1.1

India

15.6

14.2

1.3

10.3

5.2

1.5

Taiwan

12.5

15.1

(2.6)

13.6

(1.1)

0.9

Singapore

2.3

2.1

0.3

4.0

(1.6)

0.6

Thailand

2.2

0.0

2.2

2.6

(0.5)

0.8

Japan

2.0

1.1

0.9

0.0

2.0

N/A

Australia

1.6

0.7

0.9

0.0

1.6

N/A

Indonesia

1.2

3.0

(1.8)

2.2

(1.0)

0.5

Philippines

1.1

1.2

(0.1)

1.1

(0.1)

1.0

Malaysia

1.1

0.9

0.2

2.8

(1.7)

0.4

Pakistan

0.0

0.0

0.0

0.1

(0.1)

0.0

Total

100.0

100.0

100.0

Source: Invesco Asia Trust, Edison Investment Research. Note: Rebased for cash/gearing.

IAT is most underweight Hong Kong and China, which reflects diversification considerations given they account for nearly half the index. It is also underweight countries in South East Asia, including Malaysia and Indonesia, where the manager sees more market risks. In Malaysia, politics remains unclear following financial scandals associated with the previous government and the return of the 92-year old former prime minister to the post. Indonesia is perceived as one of the weaker economies in the region. As a result, its stock market and currency corrections have been particularly pronounced, presenting IAT the opportunity to add to Bank Negara International at a single-digit P/E multiple valuation.

Exhibit 4: Portfolio sector exposure vs benchmark (% unless stated)

Portfolio end-July 2018

Portfolio end-July 2017

Change
(pp)

Benchmark weight

Active weight vs index (pp)

Trust weight/ index weight (x)

Financials

29.9

24.5

5.4

23.0

6.8

1.3

Information technology

29.8

34.9

(5.1)

31.3

(1.5)

1.0

Consumer discretionary

10.0

11.7

(1.7)

8.6

1.4

1.2

Industrials

7.7

7.6

0.1

6.6

1.1

1.2

Materials

5.9

3.8

2.1

4.8

1.1

1.2

Energy

5.0

1.8

3.2

4.7

0.3

1.1

Telecom services

3.7

4.4

(0.6)

3.7

0.0

1.0

Real estate

3.2

5.0

(1.8)

6.1

(2.8)

0.5

Healthcare

1.9

1.6

0.3

3.0

(1.1)

0.6

Utilities

1.8

3.2

(1.4)

3.2

(1.4)

0.6

Consumer staples

1.1

1.6

(0.6)

4.9

(3.8)

0.2

Total

100.0

100.0

100.0

Source: Invesco Asia Trust, Edison Investment Research. Note: Rebased for cash/gearing.

As shown in Exhibit 4, IAT’s financials position increased by 5.4pp over the year to end-July 2018, making it the largest and most overweight sector exposure in the portfolio. Information technology has been reduced by 5.1pp, in large part reflecting profit-taking in the sector, which has performed strongly for much of the past two years. This included a significant trimming of the Samsung Electronics holding, which has fallen from 8.1% of the portfolio to 5.6% over the year to end-July 2018.

Recent additions to the portfolio have mainly been in cash-rich companies that the manager views as oversold or out-of-favour and command attractive valuations. These include China Communication Services (CCS), a service provider to domestic telecom operators in China; and Taiwan handset chip design company MediaTek. Both stocks were out-of-favour, suffering from a lull in the telecoms’ capital expenditure as 4G technology matured, while investment in 5G was deemed too distant for investors’ consideration. MediaTek trades on a free cash flow yield of over 10%, while cash and investments on CCS’s balance sheet represents over half its market value. Trials of 5G technology are currently underway, and its commercialisation is on the horizon for late 2019, which could signal the start of a new capex cycle for the industry, and support re-ratings for these two stocks.

Performance: Significant long-term outperformance

As shown in Exhibits 5 and 6, IAT’s NAV total return performance is significantly ahead of its benchmark over the longer periods of five and 10 years. Three-year performance is slightly ahead of the benchmark, but the absolute return is high at an annualised 22% pa. Compared to the FTSE All-Share index, IAT’s outperformance over three, five and 10 years is even more pronounced. Performance over one year, however, has lagged the benchmark. However, this will not influence the manager as IAT’s objective is to outperform over a long-term horizon of three- to five-years, looking to capitalise on the market’s short-termism.

Exhibit 5: Investment trust performance to 31 August 2018

Price, NAV and benchmark total return performance, one-year rebased

Price, NAV and benchmark total return performance (%)

Source: Thomson Datastream, Edison Investment Research. Note: Three-, five- and 10-year performance figures annualised. Benchmark is MSCI AC Asia Pacific ex-Japan until 30 April 2015 and MSCI AC Asia ex-Japan thereafter.

Exhibit 6: Share price and NAV total return performance, relative to indices (%)

 

One month

Three months

Six months

One year

Three years

Five years

10 years

Price relative to benchmark

0.4

(0.0)

(2.1)

(3.2)

1.1

14.9

28.1

NAV relative to benchmark

0.5

2.3

(0.3)

(1.3)

4.0

16.8

29.1

Price relative to FTSE All Share

3.2

(0.9)

(8.4)

(5.6)

30.7

35.9

64.1

NAV relative to FTSE All Share

3.3

1.4

(6.7)

(3.7)

34.4

38.2

65.3

Source: Thomson Datastream, Edison Investment Research. Note: Data to end-August 2018. Geometric calculation.

Exhibit 7: NAV total return performance relative to benchmark over three years

Source: Thomson Datastream, Edison Investment Research

Discount: In line with three-year average

IAT currently trades at a 10.5% discount to ex-income NAV, which is broadly in-line with the three-year average of 10.4%. The board considers an average discount of 10.0% or below to the trust’s ex-income NAV to be desirable in normal market conditions and is committed to managing the discount. Previously, it had used tender offers to buy back shares if the average discount over the financial year was greater than 10%. However, in 2017 the board reconsidered the effectiveness of this approach and concluded it to be against shareholders’ long-term interests. Instead, the board can buy back shares at its discretion, taking into account factors such as market conditions and discounts of comparable investment companies. Renewable annually, it has the ability to repurchase up to 14.99% of share capital.

Exhibit 8: Share price premium/discount to NAV (excluding income) over three years (%)

Source: Thomson Datastream, Edison Investment Research

Capital structure and fees

IAT is a conventional investment trust with one class of share. During FY18, the board conducted a tender offer for 15% of ordinary shares at a 2% discount to NAV on 11 August 2017. This resulted in the repurchase and cancellation of 12.5m shares at an average price of 312.9p per share and there are currently 70.9m shares in issue. No share repurchases have taken place during the current financial year. The trust is subject to a three-yearly continuation vote; the next is at the August 2019 AGM.

Gearing is permitted up to 25% of net assets and IAT has a £20m 364-day multi-currency revolving credit facility with The Bank of New York Mellon. Historically, use of leverage is very modest and was not deployed during FY18. As at end-July 2018, IAT had a net cash position of 3.8%. Invesco Fund Managers is paid an annual management fee of 0.75% of net assets, split 25:75 between the revenue and capital accounts. There is no performance fee. As at end-July 2018, the ongoing charge was 0.98%.

Dividend policy and record

Although IAT’s primary objective is to generate long-term capital growth rather than income, the trust has a long track record of growing or maintaining annual dividends. For FY18, revenue return per share rose to 5.98p, reflecting the higher earnings of companies within the portfolio and the continued weakness of sterling following the Brexit vote. IAT pays one dividend per year in August, and the final dividend for FY18 of 5.5p represents a 27.9% increase over FY17 and a current yield of 2.0%.

Peer group comparison

In Exhibit 9 we show 12 members of the AIC Asia Pacific ex-Japan sector, after excluding three trusts with an income mandate and a smaller trust with a shorter performance track record. IAT is one of the smallest funds. Its NAV total return has outperformed the average of the peer group over three, five and ten years; ranking fifth, fourth and fourth over these respective periods. Performance over one year has lagged, and is towards the bottom of the group. IAT’s dividend yield is above average among peers, ranking third, however, it trades at a wider than average discount to ex-par NAV, ranking seventh.

Exhibit 9: Selected peer group as at 15 September 2018*

% unless stated

Market cap £m

NAV TR
1 year

NAV TR
3 year

NAV TR
5 year

NAV TR
10 year

Discount (ex-par)

Ongoing charge

Perf.
fee

Net
gearing

Dividend yield (%)

Invesco Asia Trust

192.2

0.7

75.6

88.4

253.5

(10.7)

1.0

No

100

2.0

Aberdeen Asian Smaller

354.5

1.2

53.4

39.1

339.8

(12.1)

1.2

No

111

1.1

Aberdeen New Dawn

245.5

0.6

59.4

46.2

175.8

(12.8)

0.8

No

110

2.0

Edinburgh Dragon

656.8

0.9

59.4

48.0

183.9

(10.3)

1.1

No

102

0.9

Fidelity Asian Values

274.7

2.9

73.2

81.4

237.7

0.5

1.3

No

100

1.2

JPMorgan Asian

310.5

1.4

83.3

83.3

171.5

(11.5)

0.7

No

100

4.6

Martin Currie Asia Unconstrained

133.7

3.3

64.1

47.8

118.8

(11.8)

1.1

No

101

4.5

Pacific Assets

319.5

10.3

55.7

85.6

216.3

(1.5)

1.3

No

100

1.0

Pacific Horizon

183.1

3.1

93.6

93.4

205.9

(4.6)

1.1

No

109

0.2

Schroder Asia Pacific

705.5

(0.0)

78.6

88.7

263.8

(9.8)

1.0

No

105

1.3

Schroder Asian TR Inv. Company

305.7

1.9

76.5

93.6

200.3

4.7

1.0

Yes

105

1.4

Scottish Oriental Smaller Cos

285.9

(2.6)

45.1

48.7

335.5

(12.7)

1.0

Yes

100

1.1

Average

330.6

2.0

68.1

70.3

225.2

(7.7)

1.0

103

1.8

Trust rank in sector (12)

10

9

5

4

4

7

7

8

3

Source: Morningstar, Edison Investment Research. Note: *Performance data to 14 September 2018. TR = total return. Net gearing is total assets less cash and equivalents as a percentage of net assets (100 = ungeared).

The board

IAT’s board consists of four independent non-executive directors. At the conclusion of the 31 July 2018 AGM, Carol Ferguson retired as chairman, following over nine years of service on the board, and Neil Rogan (appointed in September 2017) assumed the role. The board believes his broad experience of investment companies, both as an investment manager and as a non-executive director, provide him with the appropriate skills to lead the trust. The nomination committee continues to review the composition of the board and succession planning. The other directors are Tom Maier (March 2009), Owen Jonathan (March 2013) and Fleur Meijs (December 2016).

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority (Financial Conduct Authority). Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Pty Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2018 Edison Investment Research Limited. All rights reserved. This report has been commissioned by Invesco Asia Trust and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable; however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Investment Research Pty Ltd (Corporate Authorised Representative (1252501) of Myonlineadvisers Pty Ltd (AFSL: 427484)) and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2018. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

295 Madison Avenue, 18th Floor

10017, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

295 Madison Avenue, 18th Floor

10017, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority (Financial Conduct Authority). Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Pty Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2018 Edison Investment Research Limited. All rights reserved. This report has been commissioned by Invesco Asia Trust and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable; however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Investment Research Pty Ltd (Corporate Authorised Representative (1252501) of Myonlineadvisers Pty Ltd (AFSL: 427484)) and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2018. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

295 Madison Avenue, 18th Floor

10017, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

295 Madison Avenue, 18th Floor

10017, New York

US

Sydney +61 (0)2 8249 8342

Level 12, Office 1205

95 Pitt Street, Sydney

NSW 2000, Australia

More on Invesco Asia Trust

View All

Latest from the Investment Companies sector

View All Investment Companies content

Research: Healthcare

Hutchison China MediTech — Fruquintinib capsules approved in China

Hutchison China MediTech’s (HCM) lead TKI asset, fruquintinib, has received China registration approval from the National Medical Products Administration of China (NMPA) for the treatment of CRC (third line). The approval serves as a major validation of the R&D innovation strategy, which HCM has cultivated over the years. This is the first innovative drug for an oncology indication, discovered and developed in China through a randomized clinical trial, to be unconditionally approved in that country. We expect launch in China by HCM and partner Eli Lilly during Q418. The approval has triggered a $13.6m milestone payment to HCM from Lilly. Our revised valuation is £74/ share.

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free